Pfizer, J&J and Merck Among Credit Suisse AG’s Heaviest Healthcare Stock Positions

Wall St. Watchdog reveals information regarding Credit Suisse AG’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 376 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $2.672 billion.

  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Credit Suisse AG reported holding 18,625,713 shares with a market value of $383,689,695. This comprised 0.57% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 16,453,063 shares with a market value of $290,890,159. This comprised 0.6% of the total portfolio. The net change in shares for this position over the two quarters is -2,172,650. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Credit Suisse AG reported holding 4,691,314 shares with a market value of $312,066,192. This comprised 0.47% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 3,616,918 shares with a market value of $230,361,502. This comprised 0.47% of the total portfolio. The net change in shares for this position over the two quarters is -1,074,396. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Credit Suisse AG reported holding 8,489,442 shares with a market value of $299,592,416. This comprised 0.45% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 5,782,059 shares with a market value of $189,073,334. This comprised 0.39% of the total portfolio. The net change in shares for this position over the two quarters is -2,707,383. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Credit Suisse AG reported holding 5,378,878 shares with a market value of $155,772,302. This comprised 0.23% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 5,213,529 shares with a market value of $163,600,536. This comprised 0.34% of the total portfolio. The net change in shares for this position over the two quarters is -165,349. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Credit Suisse AG reported holding 2,771,478 shares with a market value of $145,835,169. This comprised 0.22% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 1,920,360 shares with a market value of $98,207,209. This comprised 0.2% of the total portfolio. The net change in shares for this position over the two quarters is -851,118. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Credit Suisse AG reported holding 2,421,088 shares with a market value of $124,879,723. This comprised 0.19% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 1,803,867 shares with a market value of $83,194,344. This comprised 0.17% of the total portfolio. The net change in shares for this position over the two quarters is -617,221. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Credit Suisse AG reported holding 2,250,806 shares with a market value of $131,334,527. This comprised 0.2% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 1,344,619 shares with a market value of $73,900,259. This comprised 0.15% of the total portfolio. The net change in shares for this position over the two quarters is -906,187. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Cephalon Inc. (NASDAQ:CEPH): On 06/30/2011, Credit Suisse AG reported holding 536,655 shares with a market value of $42,878,735. This comprised 0.06% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 894,624 shares with a market value of $72,196,154. This comprised 0.15% of the total portfolio. The net change in shares for this position over the two quarters is 357,969. About Company: Cephalon, Inc. is an international biopharmaceutical company that discovers, develops, and markets biopharmaceutical products to treat neurological disorders, pain, and cancer. The Company’s products include a product that treats excessive daytime sleepiness associated with narcolepsy.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, Credit Suisse AG reported holding 2,302,929 shares with a market value of $86,428,923. This comprised 0.13% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 1,739,378 shares with a market value of $64,304,807. This comprised 0.13% of the total portfolio. The net change in shares for this position over the two quarters is -563,551. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011, Credit Suisse AG reported holding 2,217,975 shares with a market value of $91,846,344. This comprised 0.14% of the total portfolio. On 09/30/2011, Credit Suisse AG reported holding 1,636,239 shares with a market value of $63,486,072. This comprised 0.13% of the total portfolio. The net change in shares for this position over the two quarters is -581,736. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

(Note: Data regarding Credit Suisse AG’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>